Adalimumab biosimilar is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF),was created using phage display technology resulting in an antibody with human derived heavy and light chain variable regions and human IgG1:k constant regions. Adalimumab biosimilar is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) expression system and is purified by a process that includes specific viral inactivation and removal steps. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.
应用类型
该阿达木单抗 生物仿制药-科研级别产品的应用类型具体可查看提供的产品英文说明书。
免疫原
该阿达木单抗 生物仿制药-科研级别产品的免疫原,查看产品英文说明书,更多欢迎在线咨询我们。
来源宿主
Humanized
反应性
Human
保存建议
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.